Showing results (471-480 of 661) with videos related to
Sort By:
Pageof 67
Circulation. Cardiovascular Interventions|July 17, 2014
Factors associated with vascular complications in patients undergoing balloon-expandable transfemoral transcatheter aortic valve replacement via open versus percutaneous approachesMitul B Kadakia, Howard C Herrmann, Nimesh D Desai, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Cardiology Assessment of Patients Undergoing Evaluation for Orthotopic Liver TransplantationMichael S Lee, Subeer Wadia, Yerem Yeghiazarians, et al.Journal of the American College of Cardiology|May 14, 2013
4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitationLaura Mauri, Elyse Foster, Donald D Glower, et al.Circulation. Cardiovascular Quality and Outcomes|September 12, 2013
How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trialSuzanne V Arnold, John A Spertus, Yang Lei, et al.Frontiers in Immunology|February 5, 2019
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2Amanda C Herrmann, Jin S Im, Sumedha Pareek, et al.European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.Cytotherapy|August 5, 2018
Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host diseaseAbel Trujillo-Ocampo, Hyun-Woo Cho, Amanda C Herrmann, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 22, 2014
Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR)Rebecca Marcantuono, Jacob Gutsche, Maureen Burke-Julien, et al.JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.Pageof 67